| Melanie Beth Schatz, MD | |
|
85 Old Eagle School Rd, Strafford, PA 19087-2544 | |
| (610) 688-3744 | |
| (610) 688-4490 |
| Full Name | Melanie Beth Schatz |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 85 Old Eagle School Rd, Strafford, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104844372 | NPI | - | NPPES |
| SC1863626 | Other | PA | HIGHMARK BLUESHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD428010 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Paoli Hospital | Paoli, PA | Hospital |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Womens Health Group Llc | 2961316328 | 334 |
News Archive
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. presented data from its clinical development program for OBI-1, an intravenous (IV) recombinant porcine factor VIII product (rpFVIII), intended for the treatment of bleeding in people with hemophilia A with inhibitors and in people with acquired hemophilia.
Melanoma skin cancer survivors are much more likely than the general population to have future new cases of invasive melanomas and other cancers, says a national study led by UAMS' Appathurai Balamurugan, M.D., M.P.H.
Researchers from the universities of Calgary and Cambridge, UK, have discovered that a mutation in a gene necessary for the metabolism of folic acid not only impacts immediate offspring but can also have detrimental health effects, such as spina bifida and heart abnormalities, on subsequent generations.
4SC AG, the German drug discovery and development company, today announced the dosing of the first patient in its Phase II trial with 4SC-201 (resminostat), a pan-histone deacetylase (HDAC) inhibitor, as a new potential treatment option for patients with advanced hepatocellular carcinoma (HCC), the most frequent form of liver cancer.
› Verified 2 days ago
| Entity Name | Regional Womens Health Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750880118 PECOS PAC ID: 2961316328 Enrollment ID: O20180611002120 |
News Archive
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. presented data from its clinical development program for OBI-1, an intravenous (IV) recombinant porcine factor VIII product (rpFVIII), intended for the treatment of bleeding in people with hemophilia A with inhibitors and in people with acquired hemophilia.
Melanoma skin cancer survivors are much more likely than the general population to have future new cases of invasive melanomas and other cancers, says a national study led by UAMS' Appathurai Balamurugan, M.D., M.P.H.
Researchers from the universities of Calgary and Cambridge, UK, have discovered that a mutation in a gene necessary for the metabolism of folic acid not only impacts immediate offspring but can also have detrimental health effects, such as spina bifida and heart abnormalities, on subsequent generations.
4SC AG, the German drug discovery and development company, today announced the dosing of the first patient in its Phase II trial with 4SC-201 (resminostat), a pan-histone deacetylase (HDAC) inhibitor, as a new potential treatment option for patients with advanced hepatocellular carcinoma (HCC), the most frequent form of liver cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melanie Beth Schatz, MD 85 Old Eagle School Rd, Strafford, PA 19087-2544 Ph: (610) 688-3744 | Melanie Beth Schatz, MD 85 Old Eagle School Rd, Strafford, PA 19087-2544 Ph: (610) 688-3744 |
News Archive
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. presented data from its clinical development program for OBI-1, an intravenous (IV) recombinant porcine factor VIII product (rpFVIII), intended for the treatment of bleeding in people with hemophilia A with inhibitors and in people with acquired hemophilia.
Melanoma skin cancer survivors are much more likely than the general population to have future new cases of invasive melanomas and other cancers, says a national study led by UAMS' Appathurai Balamurugan, M.D., M.P.H.
Researchers from the universities of Calgary and Cambridge, UK, have discovered that a mutation in a gene necessary for the metabolism of folic acid not only impacts immediate offspring but can also have detrimental health effects, such as spina bifida and heart abnormalities, on subsequent generations.
4SC AG, the German drug discovery and development company, today announced the dosing of the first patient in its Phase II trial with 4SC-201 (resminostat), a pan-histone deacetylase (HDAC) inhibitor, as a new potential treatment option for patients with advanced hepatocellular carcinoma (HCC), the most frequent form of liver cancer.
› Verified 2 days ago
Mojdeh Saberin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 85 Old Eagle School Rd, Strafford, PA 19087 Phone: 610-688-3744 Fax: 610-688-4490 | |
Dr. Shari Leigh Senzon, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 85 Old Eagle School Rd, Strafford, PA 19087 Phone: 610-688-3744 Fax: 610-688-4490 | |
Dr. Anne L Bussard, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 85 Old Eagle School Rd, Strafford, PA 19087 Phone: 610-688-3744 Fax: 610-971-9562 | |
Suzanne Koziol Pugh, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 85 Old Eagle School Rd, Strafford, PA 19087 Phone: 610-688-3744 | |
Dr. Stephen P Krell, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 85 Old Eagle School Rd, Strafford, PA 19087 Phone: 610-688-3744 Fax: 610-688-4490 |